US20080095721A1 - Natural sunscreen compositions and processes for producing the same - Google Patents
Natural sunscreen compositions and processes for producing the same Download PDFInfo
- Publication number
- US20080095721A1 US20080095721A1 US12/001,259 US125907A US2008095721A1 US 20080095721 A1 US20080095721 A1 US 20080095721A1 US 125907 A US125907 A US 125907A US 2008095721 A1 US2008095721 A1 US 2008095721A1
- Authority
- US
- United States
- Prior art keywords
- sunscreen composition
- natural sunscreen
- delivery system
- producing
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 72
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims description 41
- 239000000284 extract Substances 0.000 claims abstract description 24
- 240000002768 Alpinia galanga Species 0.000 claims abstract description 19
- 240000003237 Hedychium spicatum Species 0.000 claims abstract description 19
- 235000006887 Alpinia galanga Nutrition 0.000 claims abstract description 14
- 235000015030 Hedychium spicatum Nutrition 0.000 claims abstract description 12
- 239000000419 plant extract Substances 0.000 claims description 28
- 150000001851 cinnamic acid derivatives Chemical class 0.000 claims description 24
- 239000006210 lotion Substances 0.000 claims description 19
- 239000006071 cream Substances 0.000 claims description 11
- 239000003921 oil Substances 0.000 claims description 11
- 230000000699 topical effect Effects 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 238000005325 percolation Methods 0.000 claims description 8
- 239000000499 gel Substances 0.000 claims description 7
- 239000002453 shampoo Substances 0.000 claims description 7
- 239000000344 soap Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 230000009931 harmful effect Effects 0.000 abstract description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 28
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 20
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 20
- 206010015150 Erythema Diseases 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 18
- 231100000321 erythema Toxicity 0.000 description 17
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 16
- 206010030113 Oedema Diseases 0.000 description 15
- 241000700198 Cavia Species 0.000 description 14
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 14
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 14
- 229960002216 methylparaben Drugs 0.000 description 14
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 14
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 14
- 229960003415 propylparaben Drugs 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 229940082500 cetostearyl alcohol Drugs 0.000 description 10
- 229960000541 cetyl alcohol Drugs 0.000 description 10
- 229940075507 glyceryl monostearate Drugs 0.000 description 10
- 229940057995 liquid paraffin Drugs 0.000 description 10
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 10
- 239000004408 titanium dioxide Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 229920001214 Polysorbate 60 Polymers 0.000 description 8
- 206010040880 Skin irritation Diseases 0.000 description 8
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- 231100000242 photoirritation Toxicity 0.000 description 8
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 8
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 8
- 229940113124 polysorbate 60 Drugs 0.000 description 8
- 229920002545 silicone oil Polymers 0.000 description 8
- 231100000475 skin irritation Toxicity 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- 229950011392 sorbitan stearate Drugs 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 206010040914 Skin reaction Diseases 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000035483 skin reaction Effects 0.000 description 7
- 231100000430 skin reaction Toxicity 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000002951 depilatory effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- 230000037072 sun protection Effects 0.000 description 4
- 229960004418 trolamine Drugs 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- OPFTUNCRGUEPRZ-QLFBSQMISA-N Cyclohexane Natural products CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 230000002026 carminative effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 206010051814 Eschar Diseases 0.000 description 2
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- -1 cinnamic acid ester Chemical class 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 231100000333 eschar Toxicity 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000036211 photosensitivity Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical class COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- UZQVYLOFLQICCT-SCSAIBSYSA-N (R)-goitrin Chemical compound C=C[C@@H]1CNC(=S)O1 UZQVYLOFLQICCT-SCSAIBSYSA-N 0.000 description 1
- DZLOUWYGNATKKZ-VMPITWQZSA-N (e)-3-(4-ethoxyphenyl)prop-2-enoic acid Chemical class CCOC1=CC=C(\C=C\C(O)=O)C=C1 DZLOUWYGNATKKZ-VMPITWQZSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- CDSIOGHZZFYFBO-UHFFFAOYSA-N CC1=CC=C(C=CC(=O)OCC2=CC=CC=C2)C=C1.CCOC1=CC=C(C=CC(C)=O)C=C1.COC1=CC=C(C=CC(C)=O)C=C1 Chemical compound CC1=CC=C(C=CC(=O)OCC2=CC=CC=C2)C=C1.CCOC1=CC=C(C=CC(C)=O)C=C1.COC1=CC=C(C=CC(C)=O)C=C1 CDSIOGHZZFYFBO-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000127225 Enceliopsis nudicaulis Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 244000062241 Kaempferia galanga Species 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 231100000569 acute exposure Toxicity 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- DHNGCHLFKUPGPX-UHFFFAOYSA-N ethyl 4-methoxycinnamate Natural products CCOC(=O)C=CC1=CC=C(OC)C=C1 DHNGCHLFKUPGPX-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- XTZZULGXHUQOEN-UHFFFAOYSA-N ethyl p-methoxycinnamate Natural products CCOC1=CC=C(C=CC(=O)OC)C=C1 XTZZULGXHUQOEN-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229940059394 kaempferia galanga root extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000002440 photoallergic dermatitis Diseases 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- This invention in general, relates to cosmetic compositions. More specifically, this invention relates to natural sunscreen compositions and processes for producing the same.
- UV rays are composed of the shorter-wavelength (290-320 nm) UVB rays that cause indirect sun tanning and the longer-wavelength (320-400 nm) UVA rays that are responsible for direct sun tanning.
- Sunscreen compositions offer a scientific solution to the above-identified harmful effects of over-exposure to the ultraviolet rays.
- Topical application sunscreen formulations are known.
- Sunscreen active are generally classified as organic sun screeners or inorganic sun screeners.
- Organic sun screeners absorb strongly at specific wavelengths and are transparent to visible light.
- some organic sun screeners such as Oxybenzone are known to cause photo allergic reactions.
- Inorganic sun screeners such as Titanium dioxide at higher levels leave visible residue referred as whitening of the skin.
- U.S. Pat. No. 6,500,869 to Driller et al. discloses a sun protection formulation in solid or liquid form containing organic or inorganic sunscreen filters for a prophylactic action.
- substances of cinnamic acid derivatives, in particular octyl p-methoxycinnamate that function not only as light protection filters, but also as solvents for other UV filters and are therefore often used in combination with various filters.
- U.S. Pat. No. 6,537,529 to Bonda et al. discloses a method of preparing a sunscreen including a solvent system and a filter system, as well as sunscreen compositions and compounds for producing sunscreen compositions.
- U.S. Pat. No. 5,773,014 to Perrier et al. discloses a composition to inhibit the formation of unwanted skin pigmentation.
- the active components of the composition include extracts of selected plants, namely, mulberry, saxifrage, grape and scutellaria root; and, preferably, ethylene diarmine tetra acetic acid (EDTA).
- EDTA ethylene diarmine tetra acetic acid
- U.S. Pat. No. 6,440,402 to Gonzalez et al. discloses the synergistic action of Kaempferia galanga root extract in sunscreen formulation.
- the invention also discloses a method comprising introducing into the composition an amount of extract of Kaempferia galanga plant sufficient to enhance the photostability of the sunscreen active.
- U.S. Pat. No. 5,756,099 to Simpson et al. discloses a process of preparing natural, organic, topical tanning sunscreen compositions comprising extracting the embryonic, spongy mass of tissue of the coconut from the drupe and adding it to the flesh of papaya in a proportional ratio of 1:3.
- Sunscreen compositions comprising herbal extracts that can act as antioxidants are known in prior art. Sunscreen compositions containing herbal extracts such as green tea, aloe vera, calendula, chamomile rosemary are also known in the art. Further, it is known in the art to devise sunscreen compositions having cinnamic acid esters, wherein the cinnamic acid esters act as sunscreen actives. The present invention is distinct from the above prior art compositions as described hereunder.
- a safe and effective natural sunscreen composition comprising extract of plant Hedychium spicatum and plant Alpinia galanga and a cosmetically acceptable carrier.
- a safe and effective natural sunscreen composition comprising extract of plant Hedychium spicatum or plant Alpinia galanga and a cosmetically acceptable carrier.
- a safe and effective natural sunscreen composition comprising cinnamic acid esters, individually or mixtures thereof, isolated and characterized from the extract of plant Hedychium spicatum and a cosmetically acceptable carrier.
- a safe and effective natural sunscreen composition comprising cinnamic acid esters, individually or mixtures thereof, isolated and characterized from the extract of plant Alpinia galanga and a cosmetically acceptable carrier.
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises Hedychium spicatum extract (0.001% to 20%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%) and Propyl paraben (0.10%) and demineralized water.
- the composition comprises Hedychium spicatum extract (0.001% to 20%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), I
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises Alpinia galanga extract (0.001% to 20%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%), Propyl paraben (0.10%), and demineralized water.
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%) and Propyl paraben (0.10%), and demineralized water.
- the composition comprises cinnamic acid esters (0.001% to 8%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 12%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%) and Propyl paraben (0.10%), and demineralized water.
- the composition comprises cinnamic acid esters (0.001% to 12%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Glyceryl mono stearate (0.250%), Stearic acid (6.50%), Light liquid paraffin (5.50%), Isopropyl myristate (1.50%), Cetyl alcohol (1.20%), Cresmer 1000 (0.80%), Cetostearyl alcohol (1.20%), Brii 36 (0.60%), Methyl paraben (0.20%), Propyl paraben (0.10%), Glycerin (5.00%), Triethanol amine (0.80%), Fragrance (qs) and DM Water (qs to 100).
- the composition comprises cinnamic acid esters (0.001% to 8%), Glyceryl mono stearate (0.250%), Stearic acid (6.50%), Light liquid paraffin (5.50%), Isopropyl myristate (1.50%), Cetyl alcohol (1.20%), Cresmer 1000 (0.80%), Cetostearyl alcohol (
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Sodium lauryl ether sulphate (40%), Cocodiethanolamide (1.00%), Betaine (5.00%), Sodium chloride (1.00%), Silicone emulsion (0.50%), Methyl paraben (0.20%), Propyl paraben (0.10%), Fragrance (qs), Colour (qs) and DM Water (qs to 100).
- the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Sodium lauryl ether sulphate (35.00%), Carbomer (1.20%), Betaine (5.00%), Triethanol amine (0.80%), Silicone emulsion (0.50%), Glycerin (5.00%), Methyl paraben (0.20%), Propyl paraben (0.10%), Fragrance (qs) and DM Water (qs to 100).
- the composition comprises cinnamic acid esters (0.001% to 8%), Sodium lauryl ether sulphate (35.00%), Carbomer (1.20%), Betaine (5.00%), Triethanol amine (0.80%), Silicone emulsion (0.50%), Glycerin (5.00%), Methyl paraben (0.20%), Propyl paraben (0.10%), Fragrance (qs) and DM Water (qs to 100).
- the present invention provides for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Hedychium spicatum by hot-soxhalation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- It is an aspect of the present invention to provide for a method for producing a natural sunscreen composition the method comprising extracting plant extracts from Alpinia galanga by percolation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- the invention provides for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Alpinia galanga by hot-soxhalation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- the invention provides for a method for producing a natural sunscreen composition, the method comprising extracting extracts of plant Hedychium spicatum or Alpinia galanga by percolation or hot-soxhalation, filtering the plant extract, purifying the extract by crystallization to obtain pure cinnamic acid esters and producing a natural sunscreen composition employing the pure cinnamic acid esters thus obtained and a cosmetically acceptable carrier.
- the invention provides for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Hedychium spicatum or Alpinia galanga by solvent extraction using an organic solvent selected from the group comprising petroleum ether, hexane, cyclohexane, benzene, dichloromethane, chloroform, ethyl acetate, acetone, methanol and ethanol, either alone or in combination thereof, purifying the resultant extract; separating the pure compound; characterizing the compound as cinnamic acid esters and producing the natural sunscreen composition using the cinnamic acid esters thus produced and a cosmetically acceptable carrier.
- an organic solvent selected from the group comprising petroleum ether, hexane, cyclohexane, benzene, dichloromethane, chloroform, ethyl acetate, acetone, methanol and ethanol, either alone or in combination thereof, purifying the resultant extract; separating the pure compound; characterizing
- the present invention provides for a delivery system containing a natural sunscreen composition comprising extract of plant Hedychium spicatum and plant Alpinia galanga and a cosmetically acceptable carrier.
- the present invention provides for a delivery system containing a natural sunscreen composition comprising extract of plant Hedychium spicatum and plant Alpinia galanga and a cosmetically acceptable carrier wherein the delivery system includes creams, shampoos, gels, lotions, soaps, oils, sticks or sprays.
- the invention involves identification and selection of the herbs and obtaining the extract by subjecting the same to solvent extraction.
- Hedychium spicatum a perennial rhizomatous herb is widely found in western and eastern parts of Himalaya. Rhizomes possess a strong aromatic odour and bitter camphoraceous taste.
- the rhizomes are stomachic, carminative, stimulant and tonic. They are used in dyspepsia. (Nadkarni, I, 608; Dastur, Useful plants, 122; Taylor & Dutt; Proc. Nat. Acad. Sci. India, 1940, 10A, 17).
- the dried rhizomes of commerce on steam distillation yield 4% of an essential oil and its main constituent being ethyl-p-methoxy cinnamate.
- the oil may be used as perfume for soaps; hair oils and face powders etc. (Taylor & Dutt, Loc. Cit; Dymock, Warden& Hooper, III, 419.
- Alpinia galanga is an herb, 1.8-2.4 m in height, with tuberous aromatic rootstocks, occurring throughout India and cultivated for its rhizomes.
- the rhizomes are considered as tonic, stomachic, carminative and stimulant, and are used as a fragrant adjunct to complex preparations and also in cough and digestive mixtures.
- the oil is carminative and in moderate doses has an anti-spasmodic action on involuntary muscle tissue.
- Disclosed herein is the process of extraction of herbs, the process comprising shade drying fresh rhizomes of Hedychium spicatum and/or Alpinia galanga and powdering the dried material coarsely.
- Each plant material is subjected to solvent extraction by percolation method.
- About 1 Kg of plant material is taken in separate flasks and soaked with petroleum ether, hexane, cyclo-hexane, benzene, dichloromethane, chloroform, ethyl acetate, acetone, methanol and ethanol for two days. All solvent extracts are drained out and filtered through Whatman Filter No. 1 and concentrated to dryness on rotatory evaporator under vacuum at optimum temperature. The residual material is extracted further until all compounds are extracted. Alternately, the extraction is also performed by hot-soxhalation method for three times and processed as above.
- the extract of the plant Hedychium spicatum is obtained by subjecting the rhizome thereof to a system of organic solvents from non-polar to polar solvents by percolation and hot-soxhalation methods.
- the solvent extraction with n-hexane under cold extraction for three days at room temperature and hot-refluxing at optimum temperature for three cycles was found to be very simple and unique process for obtaining 24.79% (highest yield of actives in comparison to other solvents used for extraction) of extract containing 60-70% of active cinnamic acid esters.
- the yields of Hedychium spicatum extract were found to be n-Hexane (24.79%), Cyclo-hexane (21.12%), Petroleum ether (15.06%), Chloroform (24.72%), Dichloromethane (14.22%), Ethyl acetate (13.87%), Acetone (17.71%), Methanol (21.61%) and Ethyl Alcohol (18.42%).
- Alpinia galanga extract The yields of Alpinia galanga extract were found to be n-Hexane (19.15%), Cyclo-hexane (18.16%), Petroleum ether (14.76%), Chloroform (21.16%), Dichloromethane (14.25%), Ethyl acetate (12.25%), Acetone (15.75%), Methanol (20.54%) and Ethyl Alcohol (17.42%).
- a crude mixture of cinnamic acid esters was analysed by HPTLC using Hexane and Ethyl acetate as mobile phase. The spots were visualized in Iodine vapour and also under UV light showing many closely related spots.
- the isolated fractions were characterized by NMR and GC-MS and identified as P-methoxy cinnamic acid esters (STR#1 to STR#5), p-ethoxy cinnamic acid esters (STR#6 to STR# 11) and p-hydroxy benzyl cinnamic acid esters (STR# 12 and STR#13).
- Primary skin irritation is a localized reversible dermal response resulting from a single application of the test substance without the involvement of the immune system.
- the skin irritation tests are usually carried out on guinea pigs or rabbits. The study is conducted using a covered patch/open application with or with out test substance. The skin reactions are observed at 24, 48 and 72 hours. This test is designed to detect the irritancy potential of the substance under investigation.
- the animals were maintained at 22 ⁇ 3° C., 50-60% of humidity, 12 hours light and dark cycle, with unlimited supply of drinking water and feed.
- the animals were housed individually in a cage.
- the fur on the dorsal area of the trunk of the animals selected for the study was removed by clipping or shaving. Care was taken to avoid abrading of the skin.
- the remaining fur on each guinea pig's back was further removed by a depilatory cream containing thioglycollic acid and, then, the depilatory cream was washed and completely removed from the back of each of the guinea pigs.
- the guinea pigs were tested 24 hours after the depilatory treatment. All the guinea pigs were weighed prior to the start of test.
- Each guinea pig treated was immobilized in an animal holder and 0.05 ml of the test substance was applied on a portion (having a size 2 ⁇ 2 cm 2 ) of the back of the guinea pig.
- Control animals received vehicle treatment.
- the skin irritation was examined at 24, 48 and 72 hours after the application. The skin reactions were assessed as described below.
- the assessment of skin irritation was done based on a graded scale of 0 to 4; with no erythema as 0; very slight erythema (barely perceptible) as 1; well defined erythema as 2; moderate to severe erythema as 3 and severe erythema (beet redness) to eschar formation (preventing grading of erythema) as 4.
- edema formation was done based on a graded scale of 0 to 4; with no edema as 0; Very slight edema (barely perceptible) as 1; Slight edema (edges of area well defined by definite raising) as 2; Moderate edema (raised approximately 1 mm) as 3 and Severe edema (raised more than 1 mm and extending beyond area of exposure) as 4.
- Group-I animals were given vehicle treatment and served as control. Animals from Group II received single topical application of Sunscreen Screen Lotion at a dose of 0.05 ml. The dermal irritancy scores were recorded at 24, 48 and 72 hours after removal of the patch. All the values are expressed as Mean ⁇ SEM. The data were analyzed statistically using Student's 1-test. The minimum level of significance was fixed at p ⁇ 0.05.
- Photoirritation test serves to indicate the existence of possible hazards likely to arise from topical application to skin of the test substance in association with exposure to light. Clinically it is characterized by skin changes showing erythema or oedema or both. Photoirritation potential may be examined by using guinea pigs.
- Photoirritation test is carried out by applying the test substance topically at appropriate concentration on the skin, which is then exposed to UV light. Skin reactions are assessed at 24, 48 and 72 hours.
- the animals were maintained at 22 ⁇ 3° C., 50-60% of humidity, 12 hours light and dark cycle, with unlimited supply of drinking water and feed.
- the animals were housed individually in a cage.
- Sun Screen Lotion was applied topically without any dilution at a dose of 0.025 ml/animal.
- the fur on the dorsal area of the trunk of the animals selected for the study was removed by clipping or shaving. Care will be taken to avoid abrading of the skin.
- the remaining fur on each guinea pig's back was further removed by a depilatory cream containing thioglycollic acid and, then, the depilatory cream was washed and completely removed from the back of each of the guinea pigs.
- the guinea pigs were tested 24 hours after the depilatory treatment. Two areas of 2.5 cm ⁇ 2.5 cm on the dorsal side (one in the left and other in the right) of the animal were marked using black marker. All the guinea pigs were weighed prior to the start of each test and the weights are recorded. The marked area in the left side served as irradiation irritation control site (IICS) and the right side received topical application of Sun Screen Lotion to serve as test. The rest of the surrounding area covered with a flank to serve as UV protected control. The animals are exposed to radiation 30 minutes after the application of the test substance. Prior to irradiation, the head of the animal is protected to avoid ocular effects.
- IICS irradiation irritation control site
- the animals were kept in a top open polypropylene cage, one at a time. All the animals were irradiated with a 300 watts Wotan Ultra Vitalux lamp for 10 minutes at a distance of 25 cm (between the lamp and the dorsal aspect of the animal). Each test site was examined at 24, 48 and 72 hours after the start of the irradiation. The responses are scored blindly under a constant artificial light source according to the following grading scale and entered in the assessment record sheet.
- UV-irradiation of animals following topical application of Sun Screen Lotion at a dose of 0.025 ml/animal showed no positive reactions of photo irritation (Table 2).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
Abstract
Description
- This is a divisional application of U.S. application Ser. No. 10/772,914, filed Feb. 5, 2004.
- 1. Field of the Invention
- This invention, in general, relates to cosmetic compositions. More specifically, this invention relates to natural sunscreen compositions and processes for producing the same.
- 2. Description of the Related Art
- Human skin is sensitive to solar rays and overexposure to sun can cause not only simple sunburn or an erythema, but also burns of varying severity. The other negative effects of over-exposure to solar rays are, tanning, immune suppression, photosensitivity or drug related photosensitivity and photo allergies. Sun can also cause the skin to lose its elasticity and form wrinkles, leading to premature ageing. Dermatosis may also be caused due to over-exposure to solar rays. In extreme cases, some people can develop skin cancer.
- Outdoor activities including typical field-related jobs and sporting activities expose the skin to sun. It has been estimated that nearly 75 percent of the sun-inflicted skin damage on the average person's skin over a lifetime is the result of being just outdoors. Hence we require a protection so that we can expose ourselves to the sunlight without getting harmed. These concerns have been heightened by evidence that the earth's ozone layer has suffered severe depletion in recent years. Ozone is recognized as the stratospheric component shielding against the harmful forms of ultraviolet radiation. But still 5% of the sunrays coming to the earth are composed of the ultraviolet rays. These ultraviolet rays are composed of the shorter-wavelength (290-320 nm) UVB rays that cause indirect sun tanning and the longer-wavelength (320-400 nm) UVA rays that are responsible for direct sun tanning. Sunscreen compositions offer a scientific solution to the above-identified harmful effects of over-exposure to the ultraviolet rays.
- Topical application sunscreen formulations are known. Sunscreen active are generally classified as organic sun screeners or inorganic sun screeners. Organic sun screeners absorb strongly at specific wavelengths and are transparent to visible light. However, some organic sun screeners such as Oxybenzone are known to cause photo allergic reactions. Inorganic sun screeners such as Titanium dioxide at higher levels leave visible residue referred as whitening of the skin.
- To overcome these allergic side effects of organic sun screeners and non-aesthetics of inorganic sun screeners, there exist the need for devising newer formulations, that can protect the skin from the harmful effects of the ultraviolet radiations of sun without any undesirable side effects. It is against this background the present invention has been brought out.
- U.S. Pat. No. 6,500,869 to Driller et al. discloses a sun protection formulation in solid or liquid form containing organic or inorganic sunscreen filters for a prophylactic action. Disclosed in this patent are substances of cinnamic acid derivatives, in particular octyl p-methoxycinnamate that function not only as light protection filters, but also as solvents for other UV filters and are therefore often used in combination with various filters.
- U.S. Pat. No. 6,537,529 to Bonda et al. discloses a method of preparing a sunscreen including a solvent system and a filter system, as well as sunscreen compositions and compounds for producing sunscreen compositions.
- U.S. Pat. No. 5,773,014 to Perrier et al. discloses a composition to inhibit the formation of unwanted skin pigmentation. The active components of the composition include extracts of selected plants, namely, mulberry, saxifrage, grape and scutellaria root; and, preferably, ethylene diarmine tetra acetic acid (EDTA).
- U.S. Pat. No. 6,440,402 to Gonzalez et al. discloses the synergistic action of Kaempferia galanga root extract in sunscreen formulation. The invention also discloses a method comprising introducing into the composition an amount of extract of Kaempferia galanga plant sufficient to enhance the photostability of the sunscreen active.
- U.S. Pat. No. 5,756,099 to Simpson et al. discloses a process of preparing natural, organic, topical tanning sunscreen compositions comprising extracting the embryonic, spongy mass of tissue of the coconut from the drupe and adding it to the flesh of papaya in a proportional ratio of 1:3.
- Sunscreen compositions comprising herbal extracts that can act as antioxidants are known in prior art. Sunscreen compositions containing herbal extracts such as green tea, aloe vera, calendula, chamomile rosemary are also known in the art. Further, it is known in the art to devise sunscreen compositions having cinnamic acid esters, wherein the cinnamic acid esters act as sunscreen actives. The present invention is distinct from the above prior art compositions as described hereunder.
- In one preferred embodiment, there is provided a safe and effective natural sunscreen composition comprising extract of plant Hedychium spicatum and plant Alpinia galanga and a cosmetically acceptable carrier.
- In another preferred embodiment, there is provided a safe and effective natural sunscreen composition comprising extract of plant Hedychium spicatum or plant Alpinia galanga and a cosmetically acceptable carrier.
- In yet another preferred embodiment, there is provided a safe and effective natural sunscreen composition comprising cinnamic acid esters, individually or mixtures thereof, isolated and characterized from the extract of plant Hedychium spicatum and a cosmetically acceptable carrier.
- In still another preferred embodiment, there is provided a safe and effective natural sunscreen composition comprising cinnamic acid esters, individually or mixtures thereof, isolated and characterized from the extract of plant Alpinia galanga and a cosmetically acceptable carrier.
- In one another preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises Hedychium spicatum extract (0.001% to 20%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%) and Propyl paraben (0.10%) and demineralized water.
- In a preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises Alpinia galanga extract (0.001% to 20%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%), Propyl paraben (0.10%), and demineralized water.
- In still another preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%) and Propyl paraben (0.10%), and demineralized water.
- In yet another preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 12%), Glyceryl mono stearate (0.55%), Cetyl alcohol (0.80%), Cetostearyl alcohol (0.50%), Heavy liquid paraffin (2.80%), Silicone oil (1.00%), Sorbitan stearate (0.68%), Isostearic acid (2.20%), Polysorbate 60 (0.50%), Acrylates copolymer (3.50%), Sodium hydroxide (0.14%), Glycerin (3.00%), Titanium dioxide (0.55%), Methyl paraben (0.20%) and Propyl paraben (0.10%), and demineralized water.
- In yet another preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Glyceryl mono stearate (0.250%), Stearic acid (6.50%), Light liquid paraffin (5.50%), Isopropyl myristate (1.50%), Cetyl alcohol (1.20%), Cresmer 1000 (0.80%), Cetostearyl alcohol (1.20%), Brii 36 (0.60%), Methyl paraben (0.20%), Propyl paraben (0.10%), Glycerin (5.00%), Triethanol amine (0.80%), Fragrance (qs) and DM Water (qs to 100).
- In yet another preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Sodium lauryl ether sulphate (40%), Cocodiethanolamide (1.00%), Betaine (5.00%), Sodium chloride (1.00%), Silicone emulsion (0.50%), Methyl paraben (0.20%), Propyl paraben (0.10%), Fragrance (qs), Colour (qs) and DM Water (qs to 100).
- In yet another preferred embodiment, the present invention provides for a safe and effective natural sunscreen composition, wherein the composition comprises cinnamic acid esters (0.001% to 8%), Sodium lauryl ether sulphate (35.00%), Carbomer (1.20%), Betaine (5.00%), Triethanol amine (0.80%), Silicone emulsion (0.50%), Glycerin (5.00%), Methyl paraben (0.20%), Propyl paraben (0.10%), Fragrance (qs) and DM Water (qs to 100).
- It is an aspect of the present invention to provide for a method of producing a natural sunscreen composition, the method comprising extracting plant extracts from Hedychium spicatum by percolation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- In still another aspect, the present invention provides for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Hedychium spicatum by hot-soxhalation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- It is an aspect of the present invention to provide for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Alpinia galanga by percolation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- In still another aspect, the invention provides for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Alpinia galanga by hot-soxhalation, filtering the plant extract, concentrating the plant extract to dryness on a rotatory evaporator under vacuum at optimum temperature and producing a natural sunscreen composition employing the said dried mass and a cosmetically acceptable carrier.
- In yet another aspect, the invention provides for a method for producing a natural sunscreen composition, the method comprising extracting extracts of plant Hedychium spicatum or Alpinia galanga by percolation or hot-soxhalation, filtering the plant extract, purifying the extract by crystallization to obtain pure cinnamic acid esters and producing a natural sunscreen composition employing the pure cinnamic acid esters thus obtained and a cosmetically acceptable carrier.
- In yet another aspect, the invention provides for a method for producing a natural sunscreen composition, the method comprising extracting plant extracts from Hedychium spicatum or Alpinia galanga by solvent extraction using an organic solvent selected from the group comprising petroleum ether, hexane, cyclohexane, benzene, dichloromethane, chloroform, ethyl acetate, acetone, methanol and ethanol, either alone or in combination thereof, purifying the resultant extract; separating the pure compound; characterizing the compound as cinnamic acid esters and producing the natural sunscreen composition using the cinnamic acid esters thus produced and a cosmetically acceptable carrier.
- In yet another preferred embodiment, the present invention provides for a delivery system containing a natural sunscreen composition comprising extract of plant Hedychium spicatum and plant Alpinia galanga and a cosmetically acceptable carrier.
- In still another preferred embodiment, the present invention provides for a delivery system containing a natural sunscreen composition comprising extract of plant Hedychium spicatum and plant Alpinia galanga and a cosmetically acceptable carrier wherein the delivery system includes creams, shampoos, gels, lotions, soaps, oils, sticks or sprays.
- The invention involves identification and selection of the herbs and obtaining the extract by subjecting the same to solvent extraction. Hedychium spicatum, a perennial rhizomatous herb is widely found in western and eastern parts of Himalaya. Rhizomes possess a strong aromatic odour and bitter camphoraceous taste.
- The rhizomes are stomachic, carminative, stimulant and tonic. They are used in dyspepsia. (Nadkarni, I, 608; Dastur, Useful plants, 122; Taylor & Dutt; Proc. Nat. Acad. Sci. India, 1940, 10A, 17). The dried rhizomes of commerce on steam distillation yield 4% of an essential oil and its main constituent being ethyl-p-methoxy cinnamate. The oil may be used as perfume for soaps; hair oils and face powders etc. (Taylor & Dutt, Loc. Cit; Dymock, Warden& Hooper, III, 419. Finnemore, 182; Wehner, I, 179, Chem Abstr; 1940, 3A, 6015). The presence of alkaloids, saponins and flavonoids has been reported in the rhizomes (Suchitra Kumar et al. J. Econ. Bot Phytochem, 1990, I, 13.) The ethanolic extract of dried rhizomes showed antibacterial activity. (Venkata Narayana et al. Indian Med. 1989, 1, 6; Mishra et al. Int J Pharmacogn, 1991, 29, 19)
- Alpinia galanga is an herb, 1.8-2.4 m in height, with tuberous aromatic rootstocks, occurring throughout India and cultivated for its rhizomes. The rhizomes are considered as tonic, stomachic, carminative and stimulant, and are used as a fragrant adjunct to complex preparations and also in cough and digestive mixtures.
- Fresh rhizomes of Alpinia galanga on steam distillation yield an essential oil (0.04%) with a peculiar strong and spicy odour. The oil contains methyl cinnamate (48%), cineol (20-30%), camphor and probably d-pipene. The oil is carminative and in moderate doses has an anti-spasmodic action on involuntary muscle tissue.
- Disclosed herein is the process of extraction of herbs, the process comprising shade drying fresh rhizomes of Hedychium spicatum and/or Alpinia galanga and powdering the dried material coarsely. Each plant material is subjected to solvent extraction by percolation method. About 1 Kg of plant material is taken in separate flasks and soaked with petroleum ether, hexane, cyclo-hexane, benzene, dichloromethane, chloroform, ethyl acetate, acetone, methanol and ethanol for two days. All solvent extracts are drained out and filtered through Whatman Filter No. 1 and concentrated to dryness on rotatory evaporator under vacuum at optimum temperature. The residual material is extracted further until all compounds are extracted. Alternately, the extraction is also performed by hot-soxhalation method for three times and processed as above.
- The extract of the plant Hedychium spicatum is obtained by subjecting the rhizome thereof to a system of organic solvents from non-polar to polar solvents by percolation and hot-soxhalation methods. The solvent extraction with n-hexane under cold extraction for three days at room temperature and hot-refluxing at optimum temperature for three cycles was found to be very simple and unique process for obtaining 24.79% (highest yield of actives in comparison to other solvents used for extraction) of extract containing 60-70% of active cinnamic acid esters.
- The yields of Hedychium spicatum extract were found to be n-Hexane (24.79%), Cyclo-hexane (21.12%), Petroleum ether (15.06%), Chloroform (24.72%), Dichloromethane (14.22%), Ethyl acetate (13.87%), Acetone (17.71%), Methanol (21.61%) and Ethyl Alcohol (18.42%).
- The yields of Alpinia galanga extract were found to be n-Hexane (19.15%), Cyclo-hexane (18.16%), Petroleum ether (14.76%), Chloroform (21.16%), Dichloromethane (14.25%), Ethyl acetate (12.25%), Acetone (15.75%), Methanol (20.54%) and Ethyl Alcohol (17.42%).
- All solvent extracts obtained as oil form are kept for crystallization at room temperature from 1 to 2 days and pure crystalline mixture thus obtained is washed with n-hexane (2 to 3 washes) and recrystallised in methanol to produce pure form of cinnamic acid esters. This method is simple, cost effective and applicable to bulk scale production.
- The isolation of individual pure compounds is achieved by column chromatography over silica gel and eluted with n-hexane and ethyl acetate mixture as each pure compound was crystallized with hexane-ethyl acetate solvent system.
- A crude mixture of cinnamic acid esters was analysed by HPTLC using Hexane and Ethyl acetate as mobile phase. The spots were visualized in Iodine vapour and also under UV light showing many closely related spots.
- The isolation of cinnamic acid esters is achieved by column chromatography over silica gel (60-120 mesh) using hexane and ethyl acetate as eluent and 250 ml fractions are collected and pooled accordingly after performing HPTLC. All fractions are subjected to 4 semi-purified fractions. Further purification of these fractions is carried on HPLC using methanol as mobile phase over RP-18 column.
-
- Preferred embodiments are further illustrated in the following examples. These examples illustrate particular embodiments of the invention and are not intended to limit the scope of the invention in any way.
-
Sl No. Ingredients % by weight 1 Hedychium spicatum extract 0.001 to 20 2 Glyceryl mono stearate 0.55 3 Cetyl alcohol 0.80 4 Cetostearyl alcohol 0.50 5 Heavy liquid paraffin 2.80 6 Silicone oil 1.00 7 Sorbitan stearate 0.68 8 Isostearic acid 2.20 9 Polysorbate 60 0.50 10 Acrylates copolymer 3.50 11 Sodium hydroxide 0.14 12 Glycerin 3.00 13 Titanium dioxide 0.55 14 Methyl paraben 0.20 15 Propyl paraben 0.10 16 DM water qs to 100
SPF: 13.97 Analysed by in vitro method using SPF 290S analyser
-
Sl No. Ingredients % by weight 1 Alpinia galanga extract 0.001 to 20 2 Glyceryl mono stearate 0.55 3 Cetyl alcohol 0.80 4 Cetostearyl alcohol 0.50 5 Heavy liquid paraffin 2.80 6 Silicone oil 1.00 7 Sorbitan stearate 0.68 8 Isostearic acid 2.20 9 Polysorbate 60 0.50 10 Acrylates copolymer 3.50 11 Sodium hydroxide 0.14 12 Glycerin 3.00 13 Titanium dioxide 0.55 14 Methyl paraben 0.20 15 Propyl paraben 0.10 16 DM water qs to 100
SPF: 12.5 Analysed by in vitro method using SPF 290S analyser
-
Sl No. Ingredients % by weight 1 A cinnamic acid esters active fraction 0.001 to 8 2 Glyceryl mono stearate 0.55 3 Cetyl alcohol 0.80 4 Cetostearyl alcohol 0.50 5 Heavy liquid paraffin 2.80 6 Silicone oil 1.00 7 Sorbitan stearate 0.68 8 Isostearic acid 2.20 9 Polysorbate 60 0.50 10 Acrylates copolymer 3.50 11 Sodium hydroxide 0.14 12 Glycerin 3.00 13 Titanium dioxide 0.55 14 Methyl paraben 0.20 15 Propyl paraben 0.10 16 DM water qs to 100
SPF: 19.12 Analysed by in vitro method using SPF 290S analyser
-
Sl No. Ingredients % by weight 1 A cinnamic acid esters active fraction 0.001 to 12 2 Glyceryl mono stearate 0.55 3 Cetyl alcohol 0.80 4 Cetostearyl alcohol 0.50 5 Heavy liquid paraffin 2.80 6 Silicone oil 1.00 7 Sorbitan stearate 0.68 8 Isostearic acid 2.20 9 Polysorbate 60 0.50 10 Acrylates copolymer 3.50 11 Sodium hydroxide 0.14 12 Glycerin 3.00 13 Titanium dioxide 0.55 14 Methyl paraben 0.20 15 Propyl paraben 0.10 16 DM water qs to 100
SPF: 20.18 Analysed by in vitro method using SPF 290S analyzer
-
Sl. No. Name of Ingredients % by weight 1. A cinnamic acid esters active fraction 0.001 to 8 2. Glyceryl monostearate 0.250 3. Stearic acid 6.50 4. Light liquid paraffin 5.50 5. Isopropyl myristate 1.50 6. Cetyl alcohol 1.20 7. Cresmer 1000 0.80 8. Cetostearyl alcohol 1.20 9. Brii 36 0.60 10. Methyl paraben 0.20 11. Propyl paraben 0.10 12. Glycerin 5.00 13. Triethanol amine 0.80 14. Fragrance qs 15. DM Water qs to 100
SPF: 19.50 Analysed by in vitro method using SPF 290S analyser
-
Sl. No. Name of Ingredients % by weight 1. A cinnamic acid esters active fraction 0.001 to 8 2. Sodium lauryl ether sulphate 40 3. Cocodiethanolamide 1.00 4. Betaine 5.00 5. Sodium chloride 1.00 6. Silicone emulsion 0.50 7. Methyl paraben 0.20 8. Propyl paraben 0.10 9. Fragrance Qs 10. Colour Qs 11. DM Water Qs to 100
SPF: 19.20 Analysed by in vitro method using SPF 290S analyser
-
Sun Protection Gel Sl. No. Name of the Ingredient % by weight 1. A cinnamic acid ester active fraction 0.001 to 8 2. Sodium lauryl ether sulphate 35.00 3. Carbomer 1.20 4. Betaine 5.00 5. Triethanol amine 0.80 6. Silicone emulsion 0.50 7. Glycerin 5.00 8. Methyl paraben 0.20 9. Propyl paraben 0.10 10. Fragrance Qs 11. DM Water Qs to 100
SPF: 20.12 Analysed by in vitro method using SPF 290S analyzer
Primary Skin Irritation Test of Sun Screen Lotion in Guinea Pigs - Primary skin irritation is a localized reversible dermal response resulting from a single application of the test substance without the involvement of the immune system. The skin irritation tests are usually carried out on guinea pigs or rabbits. The study is conducted using a covered patch/open application with or with out test substance. The skin reactions are observed at 24, 48 and 72 hours. This test is designed to detect the irritancy potential of the substance under investigation.
- Ten healthy Guinea pigs of Dunkin Hartley strain weighing from 425-500 g, bred in Experimental Animal Facility of R&D Center, The Himalaya Drug Company, were used for the study. The animals were randomized and divided into two groups of five each.
- The animals were maintained at 22±3° C., 50-60% of humidity, 12 hours light and dark cycle, with unlimited supply of drinking water and feed. The animals were housed individually in a cage. The fur on the dorsal area of the trunk of the animals selected for the study was removed by clipping or shaving. Care was taken to avoid abrading of the skin. The remaining fur on each guinea pig's back was further removed by a depilatory cream containing thioglycollic acid and, then, the depilatory cream was washed and completely removed from the back of each of the guinea pigs. The guinea pigs were tested 24 hours after the depilatory treatment. All the guinea pigs were weighed prior to the start of test. Each guinea pig treated was immobilized in an animal holder and 0.05 ml of the test substance was applied on a portion (having a size 2×2 cm2) of the back of the guinea pig. Control animals received vehicle treatment. The skin irritation was examined at 24, 48 and 72 hours after the application. The skin reactions were assessed as described below.
- The assessment of skin irritation was done based on a graded scale of 0 to 4; with no erythema as 0; very slight erythema (barely perceptible) as 1; well defined erythema as 2; moderate to severe erythema as 3 and severe erythema (beet redness) to eschar formation (preventing grading of erythema) as 4.
- The assessment of edema formation was done based on a graded scale of 0 to 4; with no edema as 0; Very slight edema (barely perceptible) as 1; Slight edema (edges of area well defined by definite raising) as 2; Moderate edema (raised approximately 1 mm) as 3 and Severe edema (raised more than 1 mm and extending beyond area of exposure) as 4.
- Group-I animals were given vehicle treatment and served as control. Animals from Group II received single topical application of Sunscreen Screen Lotion at a dose of 0.05 ml. The dermal irritancy scores were recorded at 24, 48 and 72 hours after removal of the patch. All the values are expressed as Mean ±SEM. The data were analyzed statistically using Student's 1-test. The minimum level of significance was fixed at p<0.05.
- Single application of Sunscreen Screen Lotion in guinea pigs showed no signs and symptoms of skin irritation (Table 1).
TABLE 1 Primary Skin Irritation Test of Sun Screen Lotion Skin reactions Erythema (Hours) Edema (Hours) Treatment 24 48 72 24 48 72 Control 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 0.00 0.00 0.00 0.00 0.00 Sunscreen 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± Screen 0.00 0.00 0.00 0.00 0.00 0.00 Lotion (0.05 ml/animal) - The above findings indicate that Sun Screen Lotion is devoid of skin irritation following acute exposure to guinea pigs.
- Acute Dermal Photo Irritation Test of Sun Screen Lotion in Guinea Pigs
- Photoirritation test serves to indicate the existence of possible hazards likely to arise from topical application to skin of the test substance in association with exposure to light. Clinically it is characterized by skin changes showing erythema or oedema or both. Photoirritation potential may be examined by using guinea pigs.
- Photoirritation test is carried out by applying the test substance topically at appropriate concentration on the skin, which is then exposed to UV light. Skin reactions are assessed at 24, 48 and 72 hours.
- Albino Guinea pigs of Dunkin Hartley strain bred in Experimental Animal Facility of R&D Center, The Himalaya Drug Company, were used for the study. Five animals weighing between 450-600 g were used for the study.
- The animals were maintained at 22±3° C., 50-60% of humidity, 12 hours light and dark cycle, with unlimited supply of drinking water and feed. The animals were housed individually in a cage. Sun Screen Lotion was applied topically without any dilution at a dose of 0.025 ml/animal. The fur on the dorsal area of the trunk of the animals selected for the study was removed by clipping or shaving. Care will be taken to avoid abrading of the skin. The remaining fur on each guinea pig's back was further removed by a depilatory cream containing thioglycollic acid and, then, the depilatory cream was washed and completely removed from the back of each of the guinea pigs. The guinea pigs were tested 24 hours after the depilatory treatment. Two areas of 2.5 cm×2.5 cm on the dorsal side (one in the left and other in the right) of the animal were marked using black marker. All the guinea pigs were weighed prior to the start of each test and the weights are recorded. The marked area in the left side served as irradiation irritation control site (IICS) and the right side received topical application of Sun Screen Lotion to serve as test. The rest of the surrounding area covered with a flank to serve as UV protected control. The animals are exposed to radiation 30 minutes after the application of the test substance. Prior to irradiation, the head of the animal is protected to avoid ocular effects.
- The animals were kept in a top open polypropylene cage, one at a time. All the animals were irradiated with a 300 watts Wotan Ultra Vitalux lamp for 10 minutes at a distance of 25 cm (between the lamp and the dorsal aspect of the animal). Each test site was examined at 24, 48 and 72 hours after the start of the irradiation. The responses are scored blindly under a constant artificial light source according to the following grading scale and entered in the assessment record sheet.
- The assessment of skin reactions following UV-irradiation were done for erythema on a graded scale of 0 to 4; with no erythema as 0; very slight erythema (barely perceptible) as 1; well defined erythema as 2; moderate to severe erythema as 3 and severe erythema (beet redness) to eschar formation (preventing grading of erythema) as 4.
- The assessment of skin reactions following UV-irradiation were done for edema on a graded scale of 0 to 4; with no edema as 0; Very slight edema (barely perceptible) as 1; Slight edema (edges of area well defined by definite raising) as 2; Moderate edema (raised approximately 1 mm) as 3 and Severe edema (raised more than 1 mm and extending beyond area of exposure) as 4.
- Exposure to UV-irradiation in Irradiation Irritation Control Site showed mild photo irritation at 24 and 48 hours post irradiation. UV-irradiation of animals following topical application of Sun Screen Lotion at a dose of 0.025 ml/animal showed no positive reactions of photo irritation (Table 2).
TABLE 2 Acute Dermal Photo irritation Test of Sun Screen Lotion Skin reactions Erythema (Hours) Edema (Hours) Treatment 24 48 72 24 48 72 Control 1.00 ± 1.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± (Irradiation 0.45 0.45 0.00 0.00 0.00 0.00 Irritation Control Site) Sun Screen 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± 0.00 ± Lotion (0.05 0.00 0.00 0.00 0.00 0.00 0.00 ml/animal) - The above findings indicate that Sun Screen Lotion is free of photo irritation and it can be safely used in association with exposure to light.
- While this invention has been described in detail with reference to certain preferred embodiments, it should be appreciated that the present invention is not limited to those precise embodiments. Rather, in view of the present disclosure, which describes the current best mode for practicing the invention, many modifications and variations would present themselves to those skilled in the art without departing from the scope and spirit of this invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/001,259 US20080095721A1 (en) | 2004-02-05 | 2007-12-11 | Natural sunscreen compositions and processes for producing the same |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/772,914 US7311896B2 (en) | 2004-02-05 | 2004-02-05 | Natural sunscreen compositions and processes for producing the same |
| US12/001,259 US20080095721A1 (en) | 2004-02-05 | 2007-12-11 | Natural sunscreen compositions and processes for producing the same |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/772,914 Division US7311896B2 (en) | 2004-02-05 | 2004-02-05 | Natural sunscreen compositions and processes for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20080095721A1 true US20080095721A1 (en) | 2008-04-24 |
Family
ID=34826679
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/772,914 Expired - Fee Related US7311896B2 (en) | 2004-02-05 | 2004-02-05 | Natural sunscreen compositions and processes for producing the same |
| US12/001,259 Abandoned US20080095721A1 (en) | 2004-02-05 | 2007-12-11 | Natural sunscreen compositions and processes for producing the same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/772,914 Expired - Fee Related US7311896B2 (en) | 2004-02-05 | 2004-02-05 | Natural sunscreen compositions and processes for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US7311896B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7311896B2 (en) * | 2004-02-05 | 2007-12-25 | Mmi Corporation | Natural sunscreen compositions and processes for producing the same |
| WO2006082481A1 (en) * | 2005-02-02 | 2006-08-10 | Nicholas Piramal India Limited | Herbal composition for tinea infection |
| WO2010004355A2 (en) * | 2008-07-09 | 2010-01-14 | Himalaya Global Holdings Ltd. | Novel herbal skin lightening composition, methods of producing the same and cosmeceutical compositions thereof |
| BRPI0901822A2 (en) * | 2009-05-21 | 2011-01-25 | Ybios S A | cosmetic and / or pharmaceutical formulations containing cynara scolymus and / or echinacea purpurea extracts |
| GB2472021A (en) * | 2009-07-21 | 2011-01-26 | Jurlique R & D Pty Ltd | Cosmetic sunscreen composition |
| ITBO20130279A1 (en) * | 2013-05-31 | 2014-12-01 | Phenbiox S R L | COMPOSITION FOR BODY CARE |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020155138A1 (en) * | 2001-01-19 | 2002-10-24 | Martin Katharine M. | Composition containing Hedychium extract and use thereof |
| US20030129150A1 (en) * | 2000-02-25 | 2003-07-10 | Gilles Pauly | Cosmetic preparations containing plant extracts |
| US7311896B2 (en) * | 2004-02-05 | 2007-12-25 | Mmi Corporation | Natural sunscreen compositions and processes for producing the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5773014A (en) | 1996-10-07 | 1998-06-30 | Bioetica, Inc. | Compositions and methods for inhibiting the formation of unwanted skin pigmentation |
| US5756099A (en) | 1996-12-14 | 1998-05-26 | Jewel Simpson | Natural organic tanning sunscreen compositions and methods of treatment, to reduce the risk of skin cancer caused by sunlight and ultraviolet radiation (UVA and UVB) |
| DE19811692A1 (en) | 1998-03-18 | 1999-09-23 | Merck Patent Gmbh | Sunscreen formulation containing filters preventing herpes virus activation and herpetic skin disease |
| US6440402B1 (en) | 2001-12-14 | 2002-08-27 | Avon Products, Inc. | Photostable sunscreen compositions and methods of stabilizing |
| US6537529B1 (en) | 2002-03-05 | 2003-03-25 | The C.P. Hall Company | Sunscreen compositions and methods and materials for producing the same |
-
2004
- 2004-02-05 US US10/772,914 patent/US7311896B2/en not_active Expired - Fee Related
-
2007
- 2007-12-11 US US12/001,259 patent/US20080095721A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129150A1 (en) * | 2000-02-25 | 2003-07-10 | Gilles Pauly | Cosmetic preparations containing plant extracts |
| US20020155138A1 (en) * | 2001-01-19 | 2002-10-24 | Martin Katharine M. | Composition containing Hedychium extract and use thereof |
| US7311896B2 (en) * | 2004-02-05 | 2007-12-25 | Mmi Corporation | Natural sunscreen compositions and processes for producing the same |
Also Published As
| Publication number | Publication date |
|---|---|
| US7311896B2 (en) | 2007-12-25 |
| US20050175557A1 (en) | 2005-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69832637T2 (en) | Use of compounds to protect the skin against UV-induced immunosuppression | |
| KR100862968B1 (en) | Skin Wrinkle Enhancers Containing Matrin or Oxymartrin | |
| US20080095721A1 (en) | Natural sunscreen compositions and processes for producing the same | |
| Eff et al. | In-vitro and in-vivo sunscreen activity of active compounds isolated from fruits of Phaleria marcocarpha (Scheff.) Boerl | |
| JPS6360003B2 (en) | ||
| KR20190028996A (en) | Cosmetic composition for protecting skin from UV which comprises extract of bitter ground, persimmon leaf and ceramium kondoi | |
| JP3557095B2 (en) | Melanin production inhibitor | |
| JP4201399B2 (en) | Skin aging prevention / improving agent | |
| KR20160036202A (en) | UV Protecting Cosmetic Composition Comprising Corn Cob Extract As Active Ingredient | |
| KR102402211B1 (en) | Cosmetic Composition For Prohibiting Skin Aging By Blue-Light Comprising Cynanchum Paniculatum Extract As Active Ingredient | |
| KR102713108B1 (en) | A cosmetic composition for improving skin condition or UV protection containing extract of Lithospermum erythrohizon and Scutellaria baicalensis | |
| JP4772190B2 (en) | Skin lightening agent | |
| KR100797366B1 (en) | Cosmetic composition containing as an active ingredient at least one selected from Roroton extract, white rice extract | |
| KR100789632B1 (en) | Skin whitening cosmetics containing plant extracts with melanin inhibitory activity | |
| KR100638053B1 (en) | Cosmetic composition for alleviating skin irritation containing Soru-Jin extract as an active ingredient | |
| JPH06321760A (en) | Skin beautifying agent | |
| KR100670530B1 (en) | Cosmetic composition containing as an active ingredient at least one selected from iron extract and leaf extract | |
| KR0162282B1 (en) | Cosmetic composition for sunscreen containing stilbene derivative extracted from rhubarb | |
| KR101107311B1 (en) | Skin whitening composition containing furanodienone | |
| KR20010018657A (en) | A cosmetic composition containing Sophorae Flos extracts | |
| KR100917281B1 (en) | Skin whitening improver containing saengcho extract as an active ingredient | |
| JP2006526585A (en) | Cosmetic skin lightening composition comprising an extract of a plant from the family Hyderaceae or Rubiaceae | |
| KR20160063002A (en) | Cosmetic Composition for Blocking Ultraviolet Comprising Extract of Juglans Regia | |
| KR101786853B1 (en) | Cosmetic composition for skin whitening comprising the extract of Caragana Sinica | |
| KR19990085303A (en) | Skin whitening material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: HIMALAYA GLOBAL HOLDINGS LTD., CAYMAN ISLANDS Free format text: CHANGE OF NAME;ASSIGNOR:MMI CORPORATION;REEL/FRAME:023355/0961 Effective date: 20061004 |
|
| AS | Assignment |
Owner name: HIMALAYA GLOBAL HOLDINGS LIMITED, INDIA Free format text: ASSIGNEE ADDRESS CHANGE;ASSIGNOR:HIMALAYA GLOBAL HOLDINGS LIMITED;REEL/FRAME:026357/0230 Effective date: 20110526 |
|
| AS | Assignment |
Owner name: HIMALAYA GLOBAL HOLDINGS LIMITED, UNITED ARAB EMIR Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 026357 FRAME 0230. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S ADDRESS CHANGE;ASSIGNOR:HIMALAYA GLOBAL HOLDINGS LIMITED;REEL/FRAME:026394/0074 Effective date: 20110526 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |